New Medicines in Development

Today, over 2,700 new medicines are in development, for nearly 4,600 indications. Many of these potential new medicines will fail in clinical trials, but some may represent tomorrow's new treatments. Bringing each new medicine to patients will require, on average, 10 to 15 years of testing and review.
 
This database includes medicines currently in clinical trials or at FDA for review.  The information contained in this database was derived from Wolters Kluwer Health's Adis R&D Insight database and is published with permission under license with Wolters Kluwer Health.  PhRMA has not reviewed or verified this information.

There are more than 300 medicines currently in development to treat or prevent hundreds of rare diseases, according to a new report released by the Pharmaceutical Research and Manufacturers of America (PhRMA). Genetic Alliance and the National Organization for Rare Disorders (NORD) joined PhRMA in releasing the report (read more).

Cancer
There are 750 medicines in development to treat patients with cancer, according to a new report released by the Pharmaceutical Research and Manufacturers of America (PhRMA). These treatments include 113 for lung cancer and 90 for breast cancer (read more).

Heart Disease and Stroke
A new report by the Pharmaceutical Research and Manufacturers of America (PhRMA) finds that biopharmaceutical researchers are testing 277 medicines for two of the three leading causes of death of Americans – heart disease and stroke (read more).

Neurological Conditions
A new report from the Pharmaceutical Research and Manufacturers of America (PhRMA) found that America’s pharmaceutical research companies are testing 547 new medicines to help treat neurological conditions. Learn more about potential medicines for Alzheimer's, Parkinson’s, epilepsy, sleep disorders, brain tumors, and many others (read more).

Mental Health
197 medicines are in development to help an estimated 450 million people worldwide who suffer from a mental health disorder (read more).

Aging
More than 900 new medicines are in development to treat the diseases of aging, according to a report released by the Pharmaceutical Research and Manufacturers of America (PhRMA) (read more).

HIV/AIDS
Pharmaceutical researchers are testing 92 medicines and vaccines to treat or prevent HIV/AIDS and related conditions, according to a report released by the Pharmaceutical Research and Manufacturers of America (PhRMA) (read more).

Women
More than 700 medicines for diseases that disproportionately or only affect women are currently in development, according to a report released by the Pharmaceutical Research and Manufacturers of America (PhRMA) (read more).

Children

A new report by the Pharmaceutical Research and Manufacturers of America (PhRMA) finds that biopharmaceutical researchers are testing 219 medicines to help meet the special healthcare needs of children (read more).